Calreticulin-mediated protein folding in health and disease

健康和疾病中钙网蛋白介导的蛋白质折叠

基本信息

  • 批准号:
    9238654
  • 负责人:
  • 金额:
    $ 38.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-10 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Alterations of endoplasmic reticulum (ER) homeostasis can result from mutations of chaperones or of their substrate proteins. Calreticulin is a calcium-binding ER chaperone that is important for the folding and assembly of many N-linked glycoproteins. Calreticulin is also found on the surface of macrophages and apoptotic cells, where it facilitates cellular phagocytosis. Much remains to be understood about the molecular mechanisms of calreticulin-dependent protein folding, including factors that regulate substrate binding and release in the ER. Furthermore, the extracellular functions of calreticulin are poorly understood, including the mechanisms relevant to cell-surface interactions of calreticulin, and to calreticulin-dependent phagocytosis. There is also little knowledge about the loss and gain of function of calreticulin mutants with altered calcium- binding domains that are frequently found in myleoproliferative neoplasms (MPN). Some of these gaps in knowledge will be addressed in this application. The main hypotheses are that ATP is a key regulator of calreticulin-substrate interactions and that distinct modes of protein and lipid recognition are central to the cellular functions of calreticulin. Using computational and experimental approaches, a model for the ATP binding site of calreticulin is presented. ATP binding is shown to destabilize calreticulin binding to cellular monoglucosylated major histocompatibility complex (MHC) class I molecules. The effect of ATP binding deficient mutants on the maturation of other substrates will be examined, including α1-antitrypsin (AAT), its misfolded variant ATZ, and the low-density lipoprotein-related protein (LRP-1). The molecular mechanisms by which calreticulin induces the clearance of insoluble ATZ will be studied, examining the model that polypeptide recognition by calreticulin is relevant to this activity. The influences of substrates and ER factos upon nucleotide exchange and upon the ATPase activity of calreticulin will be studied. Preliminary data indicate that the C-terminal acidic domain of calreticulin, which contains low affinity calcium-binding sites, also contains binding sites for phosphatidylserine (PS) and apoptotic cells. Somatic calreticulin mutants that are frequently present in MPN have altered non-acidic C-termini. These mutations are predicted to not only alter calcium and PS binding, and calreticulin-dependent cellular phagocytosis, but also affect the conformation and chaperone activity of calreticulin, which will be studied. Based on the knowledge gained from these studies, we expect to develop strategies to enhance the formation of active proteins in protein misfolding disorders such as AAT deficiency, and to understand the pathogenic effects of calreticulin mutations in cancer.
 描述(由申请人提供):内质网(ER)稳态的改变可能是由分子伴侣或其底物蛋白的突变引起的。钙网蛋白是一种钙结合 ER 伴侣,对于许多 N 连接糖蛋白的折叠和组装非常重要。钙网蛋白也存在于巨噬细胞和凋亡细胞的表面,促进细胞吞噬作用。关于钙网蛋白依赖性蛋白质折叠的分子机制还有很多有待了解,包括调节内质网中底物结合和释放的因素。此外,人们对钙网蛋白的细胞外功能知之甚少,包括与钙网蛋白细胞表面相互作用以及钙网蛋白依赖性吞噬作用相关的机制。对于具有改变的钙结合结构域的钙网蛋白突变体的功能丧失和获得也知之甚少,这种突变体常见于骨髓增生性肿瘤(MPN)中。本应用程序将解决其中一些知识差距。主要假设是 ATP 是钙网蛋白与底物相互作用的关键调节剂,并且蛋白质和脂质识别的不同模式对于钙网蛋白的细胞功能至关重要。使用计算和实验方法,提出了钙网蛋白 ATP 结合位点的模型。 ATP 结合显示会破坏钙网蛋白与细胞单糖基化主要组织相容性复合物 (MHC) I 类分子的结合稳定性。将检查 ATP 结合缺陷突变体对其他底物成熟的影响,包括 α1-抗胰蛋白酶 (AAT)、其错误折叠变体 ATZ 和低密度脂蛋白相关蛋白 (LRP-1)。将研究钙网蛋白诱导不溶性 ATZ 清除的分子机制,检查钙网蛋白识别多肽与该活性相关的模型。将研究底物和 ER 因子对核苷酸交换和钙网蛋白 ATP 酶活性的影响。初步数据表明,钙网蛋白的 C 端酸性结构域含有低亲和力钙结合位点,还含有磷脂酰丝氨酸 (PS) 和凋亡细胞的结合位点。 MPN 中经常出现的体细胞钙网蛋白突变体改变了非酸性 C 末端。预计这些突变不仅会改变钙和 PS 结合以及钙网蛋白依赖性细胞吞噬作用,还会影响钙网蛋白的构象和伴侣活性,对此将进行研究。基于从这些研究中获得的知识,我们期望制定策略来增强蛋白质错误折叠疾病(例如 AAT 缺乏)中活性蛋白质的形成,并了解钙网蛋白突变对癌症的致病作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MALINI RAGHAVAN其他文献

MALINI RAGHAVAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MALINI RAGHAVAN', 18)}}的其他基金

HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA I 类肽组多样性和 CD8 T 细胞对 COVID-19 疫苗的反应
  • 批准号:
    10632096
  • 财政年份:
    2022
  • 资助金额:
    $ 38.75万
  • 项目类别:
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA I 类肽组多样性和 CD8 T 细胞对 COVID-19 疫苗的反应
  • 批准号:
    10523733
  • 财政年份:
    2022
  • 资助金额:
    $ 38.75万
  • 项目类别:
Peptide Repertoires of HLA class I molecules
HLA I 类分子的肽库
  • 批准号:
    9316821
  • 财政年份:
    2017
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    10599361
  • 财政年份:
    2016
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    10362228
  • 财政年份:
    2016
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    9095546
  • 财政年份:
    2016
  • 资助金额:
    $ 38.75万
  • 项目类别:
Interactions and mechanisms of function of the TAP complex
TAP 复合体的相互作用和功能机制
  • 批准号:
    7881378
  • 财政年份:
    2009
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7881344
  • 财政年份:
    2009
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7924278
  • 财政年份:
    2009
  • 资助金额:
    $ 38.75万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7213582
  • 财政年份:
    2007
  • 资助金额:
    $ 38.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了